English Українська
  • Main
  • Useful links
  • Information for Contributors
  • About
  • Editorial board

  • Article
    Sokolik V. V.

    AGE FEATURES OF ENDOTHELIAL DYSFUNCTION AND COGNITIVE IMPAIRMENT


    About the author: Sokolik V. V.
    Heading CLINICAL MEDICINE
    Type of article Scentific article
    Annotation In 46 patients with cognitive decline and dementia were studied biochemical markers of vascular disease (ACE), endothelial dysfunction (eNOS, ET1), chronic inflammation (Аβ40, Аβ42), neurodegeneration (NSE) and using correlation and analysis of variance set their priority due to age or degree of cognitive deficit. It was shown that the intensity of vascular disease and its contribution to cognitive decline and dementia formation can be seen in such biochemical markers as the angiotensin-converting activity (ACE) and β-amyloid peptide 42, whereas dynamic of eNOS, ET1 and β-amyloid peptide 40 serum levels are primarily due to age-related changes.
    Tags age, dementia, NSE, АСЕ, еNOS, EТ1, Аβ40, Аβ42
    Bibliography
    • Voloshin P.V. Sudinna dementsiya / P.V. Voloshin, T.S. Mischenko, O.V. Dmitrieva // Mistetstvo likuvannya. – 2004. – No.5(11). – S. 36-39.
    • Gavrilova S. I. Psihicheskie rasstroystva pripervichnyih degenerativnyih (atroficheskih) protsessah golovnogo mozga. // Rukovodstvo po psihiatrii / A.S. Tiganov // - M. - 1999. T. 2.
    • Damulin I. V. Sosudistaya dementsiya / I.V. Damulin // Nevrolog. zhurn. –1999. – No.3. – S. 4-11.
    • Medvedev A. V. Sosudistyie zabolevaniya golovnogo mozga // Rukovodstvo po psihiatrii / A.S. Tiganov // - M., - 1999. T. 2.
    • Sokolik V. V. Bolezn Altsgeymera: geneticheskaya predraspolozhennost, biohimicheskie mehanizmyi i psihicheskie proyavleniya / V. V. Sokolik // Ukr. visn. psihonevrol. – 2007.– T. 15, No.3. – C. 101-105.
    • Battistin L. Vascular cognitive disorder. A biological and clinical overview / L. Battistin, A. Cagnin // Neurochem. Res. – 2010. – Vol.35, № 12. – P. 1933–1938.
    • Braak H. Where, when, and in what form does sporadic Alzheimer's disease begin? / H. Braak, K. Del Tredici //Current Opinion in Neurology. – 2012. – Vol.25, № 6. – P. 708–714.
    • Costine А. Neuron-specific enolase, but not S100B or myelin basic protein, increases in peripheral blood corresponding to lesion volume after cortical impact in piglets beth / A. Costine, Patricia B. Quebeda-Clerkin [et al.] // Journal of Neurotrauma. – 2012. – Vol. 29, № 17. – Р. 2689-2695.
    • Fadil H. Onset Dementi / H. Fadil, A. Borazanci, E.A. Haddou [et al.] // International Review of Neurobiology. – 2009. – Vol. 84. – P. 245–262.
    • Heneka M. T. Role of peroxisome proliferator-activated receptor-γ in Alzheimer's disease / M.T. Heneka, G.E. LanDreth, D.L. Feinstein // Annals of Neurology. – 2001. – Vol. 49, № 2. – P. 276.
    • Huang Y. Alzheimer mechanisms and therapeutic strategies / Y. Huang, L. Mucke // Cell. – 2012. – Vol. 148, № 6. – P. 1204-1222.
    • Maltsev A.V. Intensive protein synthesis in neurons and phosphorylation of beta_amyloid precursor protein and tauprotein are triggering factors of neuronal amyloidosis and Alzheimer’s disease / A.V. Maltsev, N.V. Dovidchenko, V.K. Uteshev [et al.] // Biomedical Chemistry. – 2013. – Vol. 7, № 4. – P. 278–293.
    • Lott I.T. Alzheimer disease and Down syndrome: factors in pathogenesis / I.T. Lott, E. Head // Neurobiol Aging. – 2005. – Vol. 26, № 3. – P. 383–389.
    • O’Brien M. D. How does cerebrovascular disease cause dementia? / M. D. O’Brien, L. Eds, A. Carlson // Vascular Dementia: Etiological, Pathogenetic, Clinical and Treatment Aspects– Basel, -1994. – P. 5–8.
    • Ronca-Testoni S. Direct spectrophotometric assay for angiotensin-converting enzyme / S. Ronca-Testoni // Clin. Chem. – 1983. – Vol. 29. – P. 1093-1096.
    • Rozemuller J. M. Role of microglia in plaque formation in senile dementia of the Alzheimer type. An immunohistochemical study /J. M. Rozemuller, P. Eikelenboom, F.C. Stam // Virchows Arch B Cell PatholInclMolPathl. – 1986. – Vol. 51. – P. 247-254.
    • Ross G. W. Vascular dementia / G. W. Ross, L. Eds, J. Thal // Cognitive Disorders: Pathophysiology and Treatment. – New York, 1992. – P. 271–289.
    • Roman G. C. Vascular dementia: diagnostic criteria for research studies. Report of the NINDS–AIREN International Workshop / G.C. Roman, T.K. Tatemichi, T. Erkinjuntti // Neurology. – 1993. – Vol. 43. – P. 250–260.
    • Rosendorff C. Cardiovascular risk factors for Alzheimer's disease / C. Rosendorff, M.S. Beeri, J.M. Silverman // Am. J.Geriatr.Cardiol. – 2007. – Vol. 16, № 3. – P. 143–149.
    • Tedgui A. Anti-Inflammatory mechanisms in the vascular wall / A. Tedgui, Z. Mallat // Circulation Research. 2001. – Vol. 88. –877p.
    • Wenk G. L. Neuropathologicchanges in Alzheimer's disease / G. L. Wenk // J Clin Psychiatry. – 2003. – Vol. 64, № 9. – P. 7–10.
    Publication of the article «World of Medicine and Biology» №3(57), 2016 year, 062-068 pages, index UDK 616.8